Home > Insider Trading > Filing (0000950170-24-023057)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
31791	Revvity Inc.	RVTY	Laboratory Analytical Instruments (3826)	042052042

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1408107	S Tajinder Vohra	940 Winter Street Waltham MA 02451	Please See Remarks	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-02-27	7,918	$54.57	34,031	No	4	M	Direct
Common Stock	Disposition	2024-02-27	2,652	$104.84	31,379	No	4	S	Direct
Common Stock	Disposition	2024-02-27	5,266	$105.66	26,113	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	NQ Stock Option (right to buy)	Acquisiton	2024-02-27	7,918	$0.00	7,918	$54.57

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2024-02-28	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 4, 2023.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $104.24 to $105.23. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $105.24 to $106.05. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
This option became exercisable in three equal annual installments beginning on February 28, 2018, which was the first anniversary of the date on which the option was granted.